Thrive Capital Management, LLC Novo Nordisk A S Transaction History

Thrive Capital Management, LLC

  • $211 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$122.71 - $146.91 $195,722 - $234,321
1,595 New
1,595 $227,000
Q4 2023

Jan 29, 2024
BUY
$87.78 - $105.45 $47,752 - $57,364
544 Added 14.79%
4,223 $436,000
Q3 2023

Nov 02, 2023
BUY
$90.94 - $199.54 $185,881 - $407,859
2,044 Added 125.02%
3,679 $334,000
Q2 2023

Aug 02, 2023
BUY
$155.98 - $172.65 $255,027 - $282,282
1,635 New
1,635 $264,000

Others Institutions Holding NVO

# of Institutions
1,954
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Thrive Capital Management, LLC Portfolio

Follow Thrive Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thrive Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email